- Home
- CVAC vs PTA Comparison
CVAC vs PTA Comparison
Compare CVAC & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CVAC | PTA |
|---|---|---|
| Founded | 2000 | 2020 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVAC | PTA |
|---|---|---|
| Price | $5.12 | $19.47 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.83 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 159.2K |
| Earning Date | 11-24-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.31% |
| EPS Growth | ★ 94.02 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $83,000,117.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.40 | N/A |
| P/E Ratio | $5.47 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.48 | $15.84 |
| 52 Week High | $5.72 | $19.67 |
Technical Indicators
Market Signals| Indicator | CVAC | PTA |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 45.91 |
| Support Level | $5.11 | $19.29 |
| Resistance Level | $5.23 | $19.59 |
| Average True Range (ATR) | 0.13 | 0.23 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 30.83 | 78.29 |
Price Performance
Historical ComparisonAbout CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.